FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech ’s NT-I7 for Advanced Pancreatic Cancer Treatment

January 30, 2024— ROCKVILLE, MD --- Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form.[i], [ii]- Pancreatic tumors are highly resistant to chemotherapy...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials